Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 295 (RNA5SP295) is a human pseudogene derived from the 5S ribosomal RNA gene family and annotated as a noncoding locus. The 5S rRNA gene cluster is generally responsible for encoding the 5S component of the large ribosomal subunit, a critical structure in protein synthesis[1][3][5]. However, **pseudogenes** such as RNA5SP295 are typically non-functional DNA copies that have lost their ability to produce functional RNA or proteins due to accumulated mutations, truncations, or lack of regulatory elements[2]. While some pseudogenes are transcribed and can, in theory, participate in gene expression regulation, competitive endogenous RNA (ceRNA) networks, or other roles (as seen for some other pseudogenes[6]), there is currently **no known functional relevance or disease association for RNA5SP295 specifically**. RNA5SP295 is a noncoding pseudogene of the human 5S ribosomal RNA gene family, not a molecule of pharmacological or therapeutic interest and not a biologically active target. It is not associated with any known drugs, mechanisms of action, or clinical biomarker roles[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 295 (RNA5SP295).